Table 1.
Study Cohort Characteristics for Nondisease Controls and Cystic Fibrosis Patient Populations
| Nondisease Controls | Cystic Fibrosis | |
|---|---|---|
| Subjects | 29 | 44 |
| Age, mean (SD) | 49.4 (16.7) | 27 (10) |
| Gender, n (%) | ||
| Male | 10 (34.5) | 23 (52.3) |
| Female | 19 (65.5) | 21 (47.7) |
| Body mass index, mean (SD) | 27.1 (5.2) | 21.4 (3.0) |
| FEV1 % predicted, mean (SD) | 96.3 (18.4) | 52.2 (19.9) |
| Disease status at time of collection, n (%) | ||
| Stable (%) | N/A | 18 (42) |
| Exacerbation (%) | N/A | 25 (58) |
| Δ508 status, n (%) | ||
| Homozygous | N/A | 25 (57) |
| Heterozygous | N/A | 14 (32) |
| Other | N/A | 5 (11) |
Definition of abbreviations: FEV1 = forced expiratory volume in 1 second; N/A = not applicable.